Independent biomedical research institute focused on aging
The Buck was a pioneer in research on aging, and now we’re a global leader in the field. We opened our doors in 1999, becoming the world’s only research institution singularly focused on the biology of aging, yielding insights into age-related diseases before they start. We hire scientists from a variety of disciplines to attack the problem from all sides because the answers we’re after won’t come from a single field. To enhance our process, we worked with world-renowned architect I.M. Pei to create a campus that literally would not allow our researchers to work in silos.
Visit website: https://www.buckinstitute.org/
Buck Institute is also referenced in the following:
Buck Institute Creations
People at Buck Institute
Buck Institute News
Mitochondria-targeted compound prevents and treats metabolic syndrome in mice
Buck Institute - 07-Jul-2023
Selectively inhibits problematic free radicals - potential breakthrough in treatment of chronic diseases & ageingRead more...
Reason reports back from Age-Related Disease Therapeutics Summit 2023
Fight Aging! - 16-Jun-2023
Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few yearsRead more...
Eye imaging can track the efficacy of interventions aimed at slowing the aging process
Buck Institute - 28-Mar-2023
Scans to know the eyeAge can provide an actionable evaluation of gero-protective therapeuticsRead more...
Lifespan.io summarises the proceedings of the Buck Institute's Longevity Summit
Lifespan.io (LEAF) - 20-Jan-2023
Another reminder of the amount of research, with multiple approaches, about to go into clinical trialsRead more...
Senolytics-a risky proposition in aging and repair mechanisms
Lifespan.io (LEAF) - 19-Oct-2022
The study is a caution for scientists engaging in self-experimentation with senolyticsRead more...
Reason reports back from October's Rejuvenation Startup Summit
Fight Aging! - 19-Oct-2022
Some really exciting developments with quite a few in clinical trialsRead more...
Racing for the lead... Underdog becomes Cyclarity Therapeutics
Longevity Technology - 20-Jun-2022
Also announces move to Buck Institute for Research on AgingRead more...
Not just vision - diet and eye health is linked to aging in fruitflies
Buck Institute - 07-Jun-2022
Staring at gadget screens at night affects circadian clock and in turn lifespanRead more...
Buck researchers discover mitochondrial protein that can increase lifespan
Buck Institute - 18-May-2022
In yeast, increasing Tom70 delays ageing related mitochondrial dysfunctionRead more...
Selah Therapeutics launched to focus on ketone-based therapies for heart disease
Longevity Technology - 13-May-2022
Treatment options for diseases of aging - from the makers of metabolic switchRead more...
A natural cholesterol metabolite with senolytic effect in mice and humans
Buck Institute - 02-Feb-2022
New class of senotherapeutic drugs that could possibly target various diseases and ageingRead more...
New study unveils the role of tau in neurodegenerative disease
Buck Institute - 20-Jan-2022
Interactions with mitochondrial & synaptic proteins highlight targets against Tau-mediated diseaseRead more...
Complicated connection between protein shape and mitochondrial health, causing aging
Buck Institute - 07-Sep-2021
The “bad” process of pore opening and the “good” process of UPRmt - connection revealedRead more...
Immune system clock tracks health, age-related disorders, and longevity
Buck Institute - 12-Jul-2021
Measuring immune health with a chemokine, CXCL9, for early disease interventionsRead more...
First ever non-invasive biomarker test to detect senolysis
Buck Institute - 02-Apr-2021
Detectible senescence-specific biomarker allows development of new drugs for age-related conditionsRead more...
Super summary of 3rd Annual Longevity Therapeutics Summit
Lifespan.io (LEAF) - 16-Feb-2021
More and more companies making greater and greater progress - 2021 could be an exciting yearRead more...
Gerostate Alpha looks at ageing in an unbiased way
Longevity Technology - 20-Jan-2021
Instead of targeting specific hallmarks/pillars - they want to target ageing as a wholeRead more...
A force of tissue stiffness could bring new changes to immune drugs
Buck Institute - 12-Jan-2021
Tissue stiffness alter immune system response to chronic diseases and ageingRead more...
Chronic inflammation promotes NAD+ decline during aging
Buck Institute - 16-Nov-2020
Senescent cells induce NAD+ decline via activation of CD8 macrophagesRead more...
Body builder supplement AKG extends lifespan and healthspan of mice
Buck Institute - 01-Sep-2020
Blood levels fall with age. NUS planning a clinical trial with middle-aged humans.Read more...
Display all news